Cohort Study: Ibuprofen Use Not Associated with Worse Outcomes in Covid-19 Patients
17 Jun, 2020 | 02:41h | UTCIbuprofen use and clinical outcomes in COVID-19 patients – Clinical Microbiology and Infection
Related Commentary on Twitter
A new cohort @CMIJournal :
403 COVID-19 patients, Ibuprofen use was NOT associated with worse clinical outcomes, compared to paracetamol or no antipyretic
Ibuprofen use and clinical outcomes in #COVID19 patients.
⛔Median age : 45, younghttps://t.co/Y4WL2UsIDU— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 12, 2020